Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma-Reference-Cited by-同舟云学术

Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma

Published:2018-05-24 Issue:8 Volume:176 Page:1079-1089
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Impagnatiello Francesco¹^ORCID,Bastia Elena¹,Almirante Nicoletta¹,Brambilla Stefania¹,Duquesroix Brigitte²,Kothe Angela C³,Bergamini Michael V W⁴⁵

Affiliation:

1. Nicox Research Institute Milan Italy

2. Nicox SA Valbonne Sophia Antipolis France

3. Silver Pharma Consulting, Inc. Buckeye AZ USA

4. Nicox Ophthalmics, Inc. Fort Worth TX USA

5. Nicox Ophthalmics, Inc. Research Triangle Park NC USA

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14328

Reference61 articles.

1. Pharmacokinetics, safety and IOP lowering profiles of omidenepag isopropyl, a selective EP2 agonist in healthy Japanese and Caucasian volunteers (phase I study);Aihara M;Invest Ophthalmol Vis Sci,2017

2. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

3. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

4. A Review of Nitric Oxide for the Treatment of Glaucomatous Disease

5. Efficacy and Tolerability of Prostaglandin Analogs

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation;Journal of Medicinal Chemistry;2024-08-20

2. From Eye Care to Hair Growth: Bimatoprost;Pharmaceuticals;2024-04-27

3. Glaucoma: A review of current management, patients’ adherence, direct and indirect cost, and barriers to drug delivery;Tropical Journal of Pharmaceutical Research;2024-02-05

4. Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review;Current Opinion in Pharmacology;2024-02

5. Rho Kinase Inhibition and Fp-Agonist Study of Rotenoids Present in Boerhavia Diffusa Root as Active Ingredient for Uveitic Glaucoma;2024